MULTIPLE MYELOMA (MM)
Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo for tough blood cancers shows early promise but study halted
Disease control TerminatedThis early-phase study tested two experimental drugs, VOB560 and MIK665, together in 37 people with relapsed or refractory non-Hodgkin lymphoma, acute myeloid leukemia, or multiple myeloma. The goal was to find safe doses and see if the combination could kill cancer cells by bloc…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
Experimental drug combo for tough myeloma shows early safety data
Disease control TerminatedThis early-stage study tested a new drug called WVT078, alone or with another drug (WHG626), in 56 people whose multiple myeloma had returned or stopped responding to at least two prior treatments. The main goal was to find a safe dose and check for side effects. The study was te…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:50 UTC